Times of Oman
Price in RO
24ct / gm
22ct / gm
Forex Rates vs R01
Back to Homepage
More patients stay on treatment with heart "polypill"
September 04, 2013 , 2 : 06 pm GST
SAVE THIS ARTICLE
Illustrative purpose only. Photo - Elmo Keep
Doctors urging heart patients to "keep taking the tablets" would have a more success if they used a new combination medicine known as a polypill, according to research published on Tuesday.
An international trial involving 2,000 patients found a four-in-one pill from Dr. Reddy's Laboratories Ltd significantly improved adherence compared with asking people to take their tablets individually.
There were also small but statistically significant improvements in blood pressure and cholesterol levels among those on the polypill, which combines aspirin, a statin to fight cholesterol and two medicines to lower blood pressure.
Dr. Simon Thom of Imperial College London, who led the study that looked at 1,000 patients in India and 1,000 in Europe over 15 months, said the polypill offered a low-cost way to improve treatment by making it simpler for patients to stay on therapy.
Poor drug compliance among those at risk of heart disease is a major problem, as people often do not feel any symptoms from their condition and so forget to take their medicine.
Average adherence to treatment after 15 months was 86 percent in patients taking the polypill against only 65 percent among those on the separate component drugs. The impact was most noticeable among those with a history of poor compliance, where the adherence rate was 77 percent compared with 23 percent.
The study results were published in the Journal of the American Medical Association.
The drugs found in the polypill are prescribed separately to millions of patients worldwide and are known to cut the risk of disease, fuelling a debate as to whether they should be routinely combined into a single, cheap treatment.
Heart specialists gathered at the European Society of Cardiology annual meeting in Amsterdam had differing views.
"We know it works well in reducing risk factors," said Dr. Koon Teo of Canada's McMaster University, who sees considerable potential in the approach. "Compliance and costs, for some poorer economies, are key benefits."
But other heart doctors said using a fixed-dose polypill would reduce their flexibility to treat patients by adjusting the type and dose of medicines according to their individual needs.
Several different versions of heart polypills are being tested in a variety of clinical trials.
Rate this Article
Rates : 1, Average : 4
Post a Comment
Did you like this section? Leave a comment!
Your Name :
Your Email Address :
Your Comment :
Enter ImageText here:
No Comments Posted
Latest in this section
Stem cell scientist calls for retraction of study
Older adults may struggle with excess possessions
Passive smoking causes irreversible damage to kids' arteries
Anger outbursts linked to swift heart attacks
Springing out of the gym into the sun? Take time to thaw out
TOP RATED ARTICLES
Ukrainians in Oman unite for peace
Mild tremor jolts Oman’s Dibba
Times News Service
Vitamin D crunch in sunny Oman
Times News Service
Royal Oman Police inks pact for buildings
African singer wows Oman audience
More in News
Urban gardens greening Berlin rooftops, airfield
Italian violinist strikes a chord with street children
Tips for writing a good article
How to choose your writing form and communicate your creative thoughts
Natasja Engholm - Special to Times of Oman
Indonesia's illegal dentists bite back after ban
More in Features
Europe and US have legitimised neo-Nazis
Turkey should avoid being in Shanghai Five
The ever-shifting borders in the Middle East
Armed neo-Nazis have taken over Ukraine
Paul Craig Roberts
France is in sight of the violence in CAR
More in Columns
Get Top news by E-mail.
Copyright © 2014 Muscat Press & Publishing House SAOC. All rights reserved. Times of Oman is not responsible for the content of external internet sites.
For reprint rights contact:
TOO Online Editorial